517 filings
Page 2 of 26
3
xr4vrmmu
2 Jan 24
Akari Therapeutics / Michael Grissinger ownership change
6:41pm
3
21nqxso
2 Jan 24
Akari Therapeutics / DONALD A WILLIAMS ownership change
6:35pm
8-K
ilsapad vc4de09l
2 Jan 24
Akari Therapeutics Announces Existing Investors Support the Company
4:30pm
6-K
upkfa2
1 Dec 23
Akari Therapeutics Appoints Experienced Life Sciences Entrepreneur Samir R. Patel, M.D. to Board of Directors
8:00am
6-K
ew0q1 mggz
16 Nov 23
Current report (foreign)
8:00am
424B3
9uanzn7tz
27 Oct 23
Prospectus supplement
4:15pm
EFFECT
290m43plsu0re1k
27 Oct 23
Notice of effectiveness
12:15am
CORRESP
1414cpum
25 Oct 23
Correspondence with SEC
12:00am
EFFECT
mwmjbd5
24 Oct 23
Notice of effectiveness
12:15am
EFFECT
n5y4ixkz2 ws
24 Oct 23
Notice of effectiveness
12:15am
UPLOAD
q96q cyrsoqfwgw8jk3i
24 Oct 23
Letter from SEC
12:00am
SC 13D/A
wlgr ctbpi5wp047i
20 Oct 23
Akari Therapeutics / RPC Pharma ownership change
5:00pm
POS AM
1xbqm1f6g
20 Oct 23
Prospectus update (post-effective amendment)
4:29pm
POS AM
3taydh
20 Oct 23
Prospectus update (post-effective amendment)
4:28pm
F-3
ezeokppwh3u0zy5kam3
20 Oct 23
Shelf registration (foreign)
4:23pm
D
fwifaf46 cdffi9q
19 Oct 23
$1.97 mm in equity / options / securities to be acquired, sold $1.97 mm, 11 investors
4:17pm
S-8
5veva8
12 Oct 23
Registration of securities for employees
4:43pm
6-K
41dzg8
29 Sep 23
Current report (foreign)
8:01am
6-K
2vnnf9smn 98lpn
21 Sep 23
Akari Therapeutics Announces Existing Investors Support the Company
8:00am
6-K
c6m2 7hpjwjnag
5 Sep 23
Current report (foreign)
9:00am